Insider trades
Espinoza Octavio, CFO of Ligand Pharmaceuticals LGND, has filed 2 purchases and 23 sales on the open market. Over the past 12 months that comes to a net sale of $3.8M. The latest trade was on 05/27.
Espinoza Octavio
CFO
- Company
- Ligand Pharmaceuticals LGND
- First filing
- 23/01/04
- Trades
- 100 trades
- Buys / sales
- 2 / 23
- 12-month net buying
- −$3.8M
- Last trade
- 05/27
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/11 | 03/13 | 3,057 sh | $225.00 | $687,825 | −12.7% | |
LGND | Open-market sale10b5-1 plan | 03/04 | 03/06 | 13,423 sh11 trades | $205.83avg. | $2,762,844.76 | −38.3% |
| Open-market sale | 25/12/12 | 25/12/16 | 1,804 sh | $188.31 | $339,711.24 | −6.4% | |
LGND | Open-market buy | 25/05/09 | 25/05/13 | 1,500 sh2 trades | $104.06avg. | $156,090 | +5.7% |
| Open-market sale | 25/03/04 | 25/03/06 | 5,000 sh | $115.03 | $575,150 | −20.9% | |
| Open-market sale | 24/12/23 | 24/12/26 | 2,104 sh | $116.37 | $244,842.48 | −9.2% | |
LGND | Open-market sale | 24/09/20 | 24/09/24 | 1,275 sh3 trades | $103.94avg. | $132,517.5 | −4.9% |
LGND | Open-market sale | 24/05/15–24/05/17 | 24/05/17 | 13,293 sh4 trades | $86.26avg. | $1,146,708.57 | −36.2% |
| Open-market sale | 24/02/28 | 24/02/29 | 140 sh | $88.46 | $12,384.4 | −0.5% |